Senior Quality & Regulatory Consulting for Defensible Decisions
Senior Quality and Regulatory support for regulated companies preparing for market entry, validation, audit, remediation, or growth.
SENIOR-LED CONSULTING
Senior judgment, applied directly to the decision
Efraín Ghio, Founder and Senior Quality and Regulatory Affairs Advisor, brings more than two decades of experience across pharmaceutical Quality Control, Quality Assurance, regulated manufacturing, audits, CAPA, investigations, validation and computerized systems.
Clients work directly with the senior advisor framing the risk, reviewing the evidence and supporting implementation—without layers of junior hand-offs.
When Quality and Regulatory Decisions Become Business-Critical
The highest-risk moments are rarely about producing more documentation. They are about knowing what the evidence can support before the next business milestone.
Entering a New Market
Clarify the regulatory pathway, evidence requirements and critical gaps before committing resources, timelines or commercial claims.
Preparing for an Audit or Inspection
Identify weaknesses in the Quality System, evidence trail and execution before they become findings, delays or remediation costs.
Validating a GxP Digital System
Define intended use, risk, validation evidence, data integrity and responsibilities before regulated users depend on the system.
Scaling or Remediating a Quality System
Strengthen processes, CAPA effectiveness and governance without adding unnecessary documentation or bureaucracy.
Quality and Regulatory Support Built Around the Decision You Need to Make
From market readiness and quality systems to GxP digital validation and remediation, our work is scoped around the evidence, risks and actions required to move forward with confidence.
Regulatory & Market Readiness
Clarify the regulatory pathway, evidence requirements, claims and critical gaps that could delay market entry or commercialization.
Quality Systems & Audit Readiness
Strengthen the Quality System, evidence trail and execution before audits, inspections, customer diligence or growth expose weaknesses.
GxP Digital Systems, CSA & Part 11
Define intended use, risk, validation evidence, data integrity, audit trail expectations and customer/vendor responsibilities for regulated digital systems.
Remediation, CAPA & Investigation Effectiveness
Turn findings, deviations and CAPAs into evidence of effective control rather than documentation that closes on paper but leaves the underlying risk unresolved.
Fractional Quality & Regulatory Advisory
Add senior Quality and Regulatory judgment when the business needs ongoing support, without adding permanent full-time headcount.
Product & Marketplace Compliance
Reduce launch and enforcement risk around labeling, claims, substantiation, cosmetics, supplements, imports and marketplace compliance.
Industries We Support
We work with regulated organizations where Quality and Regulatory decisions directly affect market access, customer trust and the ability to scale.
MedTech & Digital Health
Medical devices, SaMD, digital health products and manufacturers preparing for FDA, EU MDR or commercial expansion.
Pharma, Biotech & CDMO
Pharma, biotech and manufacturing organizations strengthening GMP systems, investigations, CAPA, suppliers and inspection readiness.
GxP SaaS & Digital Systems
SaaS, eQMS, LIMS, ELN and other digital platforms serving regulated life-science customers.
Consumer Products & Marketplace Compliance
Brands, manufacturers and sellers managing labeling, claims, substantiation, cosmetics, supplements, imports and marketplace requirements.
Start with a Regulatory & Quality Readiness Assessment
Before committing to a pathway, remediation plan or validation strategy, understand what your current evidence can actually support, where the material gaps are, and what should happen next.
How We Work
01 — Assess
Understand the decision, intended outcome, evidence base and business milestone.
02 — Prioritize
Separate material risks and evidence gaps from lower-value activity and unnecessary bureaucracy.
03 — Implement & Defend
Build the evidence, controls and execution needed to support the decision under real regulatory or business scrutiny.
Why QA PharmaPro
Senior Expertise, Applied Directly
Senior Quality and Regulatory judgment without layers of junior hand-offs or account-management overhead.
Evidence Before Assumptions
We begin with what the decision must be able to defend, then evaluate what the current evidence actually supports.
Risk-Based and Proportionate
More documentation does not automatically mean more compliance. Controls should be aligned with intended use, risk and business reality.
From Assessment to Execution
When appropriate, we stay through implementation so recommendations become usable evidence, controls and decisions.
Built for Regulated Growth
Quality and Regulatory systems should support market access, customer confidence and scalable operations—not become the bottleneck.
Selected Engagements
Examples of the types of decisions and evidence challenges we support. Client identities are kept confidential.
Private-Label Medical Device Market Entry
Mapped regulatory responsibilities, documentation gaps and a staged pathway for a brand owner preparing to commercialize FDA-cleared devices under private label.
GxP SaaS / Part 11 Readiness
Translated intended use, risk, audit-trail expectations and validation responsibilities into a defensible readiness path for regulated customers.
Quality System Remediation
Prioritized systemic gaps, CAPA effectiveness and governance improvements so remediation work addressed actual risk rather than adding documentation volume.
When the Need Is Ongoing, the Engagement Can Be Too
Some companies do not need another full-time hire. They need recurring access to senior Quality and Regulatory judgment as products, systems, audits and commercial priorities evolve.
Decision Support & Escalation
Senior review for regulatory choices, Quality risks, customer questions and issues that should not wait for the next project.
Prioritized Monthly Support
A defined advisory cadence around the highest-value reviews, decisions and evidence gaps rather than an open-ended bucket of hours.
Capacity Without Permanent Headcount
Flexible senior capacity for organizations that need continuity now but are not ready to build a larger internal function.
Insights for Decisions That Cannot Rely on Assumptions
Practical analysis on regulatory strategy, Quality systems, digital compliance, audits and remediation — focused on what the evidence can actually support and what the business should decide next.
Make the Next Decision Defensible
Have a Quality, Regulatory, or compliance matter that requires experienced judgment? Write to us directly. Every inquiry is reviewed personally, and we will identify the most appropriate next step.